246 related articles for article (PubMed ID: 7884588)
1. p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland.
Czyz W; Joensuu H; Pylkkänen L; Klemi PJ
J Pathol; 1994 Dec; 174(4):267-74. PubMed ID: 7884588
[TBL] [Abstract][Full Text] [Related]
2. DNA aneuploidy in follicular adenomas of the thyroid gland.
Joensuu H; Klemi P; Eerola E
Am J Pathol; 1986 Sep; 124(3):373-6. PubMed ID: 3766698
[TBL] [Abstract][Full Text] [Related]
3. Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland.
Holm R; Nesland JM
J Pathol; 1994 Mar; 172(3):267-72. PubMed ID: 8195930
[TBL] [Abstract][Full Text] [Related]
4. Pathobiology of pituitary adenomas and carcinomas.
Scheithauer BW; Gaffey TA; Lloyd RV; Sebo TJ; Kovacs KT; Horvath E; Yapicier O; Young WF; Meyer FB; Kuroki T; Riehle DL; Laws ER
Neurosurgery; 2006 Aug; 59(2):341-53; discussion 341-53. PubMed ID: 16883174
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
Belessi CJ; Parasi AS; Manioudaki HS; Laoutaris NP; Legakis NC; Peros GT; Androulakis GA
J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
[TBL] [Abstract][Full Text] [Related]
6. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
[TBL] [Abstract][Full Text] [Related]
7. Correlations of morphology, proliferation indices, and oncogene activation in ductal breast carcinoma: nuclear grade, S-phase, proliferating cell nuclear antigen, p53, epidermal growth factor receptor, and c-erb-B-2.
Dabbs DJ
Mod Pathol; 1995 Aug; 8(6):637-42. PubMed ID: 8532697
[TBL] [Abstract][Full Text] [Related]
8. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis. A comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry, and p53.
Oshiro Y; Fukuda T; Tsuneyoshi M
Am J Surg Pathol; 1994 Jul; 18(7):712-9. PubMed ID: 7517104
[TBL] [Abstract][Full Text] [Related]
9. Nuclear DNA content, S-phase fraction analysis and expression of proliferating cell nuclear antigen (PCNA) of normal and hyperplastic/neoplastic parathyroid glands.
Suzuki S; Tsuchiya A; Hara K; Abe R
Fukushima J Med Sci; 1997 Jun; 43(1):41-50. PubMed ID: 9431783
[TBL] [Abstract][Full Text] [Related]
10. Ampullary carcinoma: prognostic significance of ploidy, cell-cycle analysis and proliferating cell nuclear antigen (PCNA).
Crucitti A; Masetti R; Breccia C; Coppola R; Magistrelli P; Nuzzo G; Maggiano N; Picciocchi A
Hepatogastroenterology; 1999; 46(26):1187-91. PubMed ID: 10370689
[TBL] [Abstract][Full Text] [Related]
11. [Morphological atypism and clinicopathological factors in colorectal adenoma and cancer using nuclear DNA content, p53 and PCNA].
Yamamoto H; Yamada N; Asano G; Shoji T
Nihon Geka Gakkai Zasshi; 1994 Oct; 95(10):763-74. PubMed ID: 7823898
[TBL] [Abstract][Full Text] [Related]
12. Discerning malignancy in human adrenocortical neoplasms: utility of DNA flow cytometry and immunohistochemistry.
Suzuki T; Sasano H; Nisikawa T; Rhame J; Wilkinson DS; Nagura H
Mod Pathol; 1992 May; 5(3):224-31. PubMed ID: 1353877
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen.
Chae YS; Flotte T; Hsu DW; Preffer F; Hedley-Whyte ET
Gen Diagn Pathol; 1996 Oct; 142(2):89-95. PubMed ID: 8950573
[TBL] [Abstract][Full Text] [Related]
14. [Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer].
Yan XJ; Liang LZ; Li DC; Li JL; Zhang CQ; Yuan SH
Ai Zheng; 2004 Jan; 23(1):74-80. PubMed ID: 14720380
[TBL] [Abstract][Full Text] [Related]
15. Clinical tumor growth and comparison with proliferation markers in non-functioning (inactive) pituitary adenomas.
Saeger W; Lüdecke B; Lüdecke DK
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):80-5. PubMed ID: 18072009
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
Tanioka F; Hiroi M; Yamane T; Hara H
Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
[TBL] [Abstract][Full Text] [Related]
17. Adenomas and follicular carcinomas of the thyroid display two major patterns of chromosomal changes.
Castro P; Eknaes M; Teixeira MR; Danielsen HE; Soares P; Lothe RA; Sobrinho-Simões M
J Pathol; 2005 Jul; 206(3):305-11. PubMed ID: 15852498
[TBL] [Abstract][Full Text] [Related]
18. Clinical meaning of DNA content in the long term behaviour of follicular thyroid tumours: a 12-year follow up.
Lukács GL; Balázs G; Zs-Nagy I; Mikó T
Eur J Surg; 1994 Aug; 160(8):417-23. PubMed ID: 7811827
[TBL] [Abstract][Full Text] [Related]
19. P53 protein immunohistochemical expression in colonic adenomas with and without associated carcinoma.
Saleh HA; Aburashed A; Bober P; Tabaczka P
Am J Gastroenterol; 1998 Jun; 93(6):980-4. PubMed ID: 9647033
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis and immunohistochemical staining for the p53 protein and proliferating cell nuclear antigen in submucosal carcinoma of the esophagus.
Kimura H; Konishi K; Maeda K; Yabushita K; Kuroda Y; Tsuji M; Miwa A
Hepatogastroenterology; 1999; 46(25):285-9. PubMed ID: 10228808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
